K. H. Bjørlykke

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases

Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll et al. · JAMA · 2021 · 147 citations · Full text

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter et al. · RMD Open · 2022 · 32 citations · Full text

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

K. H. Bjørlykke, Hilde S Ørbo, Anne Therese Tveter et al. · The Lancet Rheumatology · 2022 · 24 citations · Full text

Vaccination, Vaccine Development, Medicine +9

Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials

Marthe Kirkesæther Brun, Johanna Elin Gehin, K. H. Bjørlykke et al. · The Lancet Rheumatology · 2024 · 15 citations

Anti-inflammatory, Autoimmune Disease, Nor-drum Trials +12